Regulations.gov document
Breast Enhanced Scintigraphy Test (B.E.S.T.) Imaging Utilizes Vascularity/Angiogenesis and…
Supporting & Related Material · FDA-2018-P-3102 · posted Aug 9, 2018
Key facts
| Document ID | FDA-2018-P-3102-0003 |
|---|---|
| Title | Breast Enhanced Scintigraphy Test (B.E.S.T.) Imaging Utilizes Vascularity/Angiogenesis and Mitochondrial Activity to Distinguish Between Normal Breast Tissue, Inflammation and Breast Cancer re: Citizen Petition from Richard M Fleming |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-3102 |
| Posted | Aug 9, 2018 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: